Trials / Terminated
TerminatedNCT00453908
Alfuzosin Versus Placebo in Acute Urinary Retention
Does Alfuzosin OD vs. Placebo in Male Patients Facilitate Spontaneous Voiding During Clean Intermittent Self-Catheterization Following Acute Urinary Retention?
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to investigate if 14 days of treatment with Alfuzosin compared to placebo, will increase the number of patients with satisfying spontaneous voiding after acute urinary retention treated with Clean Self-Catheterization. Furthermore is investigated the safety of the medical treatment and self-catheterization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alfuzosin |
Timeline
- Start date
- 2004-05-01
- First posted
- 2007-03-29
- Last updated
- 2007-08-20
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00453908. Inclusion in this directory is not an endorsement.